The authors also indicated the necessity to study a patient cohort with a large number of patients differing in IGHV-mutation status to determine if the generation of intraclonal IGHV-IGHD-IGHJ variants differed between U-CLL and M-CLL clones. This evidence concerns the gene IGHD and B-cell chronic lymphocytic leukemia.